Retro-inverso isomer of angiopep-2: A stable d -peptide ligand inspires brain-targeted drug delivery

Molecular Pharmaceutics

Volumn 11, Issue 10, 2014, Pages 3261-3268

  Wei, Xiaoli ^a   Zhan, Changyou ^a   Chen, Xishan ^a   Hou, Jiapeng ^a   Xie, Cao ^a   Lu, Weiyue ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Angiopep 2; brain targeted drug delivery; glioblastoma; PEG DSPE micelle; retro inverso isomer

Indexed keywords

ANGIOPEP 2; CELL PROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RELATED PROTEIN 1; UNCLASSIFIED DRUG; ANGIOPEP-2; MICELLE; PEPTIDE;

ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; GLIOBLASTOMA CELL LINE; IN VIVO STUDY; ISOMER; ISOMERIZATION; MICELLE; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; RAT; TRANSCYTOSIS; ANIMAL; BRAIN NEOPLASMS; CHEMISTRY; GLIOBLASTOMA; HUMAN; METABOLISM; PROCEDURES; TUMOR CELL LINE;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; GLIOBLASTOMA; HUMANS; MICELLES; PEPTIDES; RATS;

EID: 84907990121     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500086e     Document Type: Article

References (38)

1. Hawkins, B. T.; Davis, T. P. The blood-brain barrier/neurovascular unit in health and disease Pharmacol. Rev. 2005, 57 (2) 173-85
2. Hutchinson, E. Blood-brain barrier: Plugging the leak Nat. Rev. Neurosci. 2010, 11 (12) 789
3. Fishman, J. B.; Rubin, J. B.; Handrahan, J. V.; Connor, J. R.; Fine, R. E. Receptor-mediated transcytosis of transferrin across the blood-brain barrier J. Neurosci. Res. 1987, 18 (2) 299-304
4. Pardridge, W. M.; Eisenberg, J.; Yang, J. Human blood-brain barrier transferrin receptor Metabolism 1987, 36 (9) 892-5
5. Fillebeen, C.; Descamps, L.; Dehouck, M. P.; Fenart, L.; Benaissa, M.; Spik, G.; Cecchelli, R.; Pierce, A. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier J. Biol. Chem. 1999, 274 (11) 7011-7
6. Dehouck, B.; Fenart, L.; Dehouck, M. P.; Pierce, A.; Torpier, G.; Cecchelli, R. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier J. Cell Biol. 1997, 138 (4) 877-89
7. Kumar, P.; Wu, H.; McBride, J. L.; Jung, K. E.; Kim, M. H.; Davidson, B. L.; Lee, S. K.; Shankar, P.; Manjunath, N. Transvascular delivery of small interfering RNA to the central nervous system Nature 2007, 448 (7149) 39-43
8. Son, S.; Hwang do, W.; Singha, K.; Jeong, J. H.; Park, T. G.; Lee, D. S.; Kim, W. J. RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain J. Controlled Release 2011, 155 (1) 18-25
9. Zhan, C.; Li, B.; Hu, L.; Wei, X.; Feng, L.; Fu, W.; Lu, W. Micelle-based brain-targeted drug delivery enabled by a nicotine acetylcholine receptor ligand Angew. Chem., Int. Ed. 2011, 50 (24) 5482-5
10. Demeule, M.; Currie, J. C.; Bertrand, Y.; Che, C.; Nguyen, T.; Regina, A.; Gabathuler, R.; Castaigne, J. P.; Beliveau, R. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2 J. Neurochem. 2008, 106 (4) 1534-44
11. Li, J.; Zhang, C.; Fan, L.; Jiang, X.; Chen, J.; Pang, Z.; Zhang, Q. Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides Pharm. Res. 2013, 30 (7) 1813-23
12. Li, J.; Feng, L.; Fan, L.; Zha, Y.; Guo, L.; Zhang, Q.; Chen, J.; Pang, Z.; Wang, Y.; Jiang, X.; Yang, V. C.; Wen, L. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides Biomaterials 2011, 32 (21) 4943-50
13. Demeule, M.; Regina, A.; Che, C.; Poirier, J.; Nguyen, T.; Gabathuler, R.; Castaigne, J. P.; Beliveau, R. Identification and design of peptides as a new drug delivery system for the brain J. Pharmacol. Exp. Ther. 2008, 324 (3) 1064-72
14. Regina, A.; Demeule, M.; Che, C.; Lavallee, I.; Poirier, J.; Gabathuler, R.; Beliveau, R.; Castaigne, J. P. Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2 Br. J. Pharmacol. 2008, 155 (2) 185-97
15. Drappatz, J.; Brenner, A.; Wong, E. T.; Eichler, A.; Schiff, D.; Groves, M. D.; Mikkelsen, T.; Rosenfeld, S.; Sarantopoulos, J.; Meyers, C. A.; Fielding, R. M.; Elian, K.; Wang, X.; Lawrence, B.; Shing, M.; Kelsey, S.; Castaigne, J. P.; Wen, P. Y. Phase I study of GRN1005 in recurrent malignant glioma Clin. Cancer Res. 2013, 19 (6) 1567-76
16. Shao, K.; Huang, R.; Li, J.; Han, L.; Ye, L.; Lou, J.; Jiang, C. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain J. Controlled Release 2010, 147 (1) 118-26
17. Xin, H.; Jiang, X.; Gu, J.; Sha, X.; Chen, L.; Law, K.; Chen, Y.; Wang, X.; Jiang, Y.; Fang, X. Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma Biomaterials 2011, 32 (18) 4293-305
18. Xin, H.; Sha, X.; Jiang, X.; Zhang, W.; Chen, L.; Fang, X. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles Biomaterials 2012, 33 (32) 8167-76
19. Huang, R.; Ma, H.; Guo, Y.; Liu, S.; Kuang, Y.; Shao, K.; Li, J.; Liu, Y.; Han, L.; Huang, S.; An, S.; Ye, L.; Lou, J.; Jiang, C. Angiopep-conjugated nanoparticles for targeted long-term gene therapy of Parkinson's disease Pharm. Res. 2013, 30 (10) 2549-59
20. Huang, S.; Li, J.; Han, L.; Liu, S.; Ma, H.; Huang, R.; Jiang, C. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma Biomaterials 2011, 32 (28) 6832-8
21. Yan, H.; Wang, L.; Wang, J.; Weng, X.; Lei, H.; Wang, X.; Jiang, L.; Zhu, J.; Lu, W.; Wei, X.; Li, C. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier ACS Nano 2012, 6 (1) 410-20
22. Li, Y.; Lei, Y.; Wagner, E.; Xie, C.; Lu, W.; Zhu, J.; Shen, J.; Wang, J.; Liu, M. Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells Bioconjugate Chem. 2013, 24 (1) 133-43
23. el-Bacha, R. S.; Minn, A. Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain Cell. Mol. Biol. (Noisy-le-grand) 1999, 45 (1) 15-23
24. Yan, Z.; Wang, F.; Wen, Z.; Zhan, C.; Feng, L.; Liu, Y.; Wei, X.; Xie, C.; Lu, W. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor J. Controlled Release 2012, 157 (1) 118-25
25. Zhan, C.; Yan, Z.; Xie, C.; Lu, W. Loop 2 of Ophiophagus hannah toxin b binds with neuronal nicotinic acetylcholine receptors and enhances intracranial drug delivery Mol. Pharmaceutics 2010, 7 (6) 1940-7
26. Zhan, C.; Meng, Q.; Li, Q.; Feng, L.; Zhu, J.; Lu, W. Cyclic RGD-polyethylene glycol-polyethylenimine for intracranial glioblastoma-targeted gene delivery Chem. Asian J. 2012, 7 (1) 91-6
27. Shen, J.; Zhan, C.; Xie, C.; Meng, Q.; Gu, B.; Li, C.; Zhang, Y.; Lu, W. Poly(ethylene glycol)-block-poly(D,L-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery J. Drug Targeting 2011, 19 (3) 197-203
28. Gao, X.; Qian, J.; Zheng, S.; Xiong, Y.; Man, J.; Cao, B.; Wang, L.; Ju, S.; Li, C. Up-regulating blood brain barrier permeability of nanoparticles via multivalent effect Pharm. Res. 2013, 30 (10) 2538-48
29. Li, C.; Pazgier, M.; Li, J.; Liu, M.; Zou, G.; Li, Z.; Chen, J.; Tarasov, S. G.; Lu, W. Y.; Lu, W. Limitations of peptide retro-inverso isomerization in molecular mimicry J. Biol. Chem. 2010, 285 (25) 19572-81
30. Li, C.; Zhan, C.; Zhao, L.; Chen, X.; Lu, W. Y.; Lu, W. Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction Bioorg. Med. Chem. 2013, 21 (14) 4045-50
31. Chaturvedi, N.; Goodman, M.; Bowers, C. Topochemically related hormone structures. Synthesis of partial retro-inverso analogs of LH-RH Int. J. Pept. Protein Res. 1981, 17 (1) 72-88
32. Bickel, U.; Yoshikawa, T.; Pardridge, W. M. Delivery of peptides and proteins through the blood-brain barrier Adv Drug Deliv Rev 2001, 46 (1-3) 247-79
33. Broadwell, R. D.; Baker-Cairns, B. J.; Friden, P. M.; Oliver, C.; Villegas, J. C. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor Exp. Neurol. 1996, 142 (1) 47-65
34. Markoutsa, E.; Pampalakis, G.; Niarakis, A.; Romero, I. A.; Weksler, B.; Couraud, P. O.; Antimisiaris, S. G. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line Eur. J. Pharm. Biopharm. 2011, 77 (2) 265-74
35. Zhan, C.; Wei, X.; Qian, J.; Feng, L.; Zhu, J.; Lu, W. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo J. Controlled Release 2012, 160 (3) 630-6
36. Zhan, C.; Gu, B.; Xie, C.; Li, J.; Liu, Y.; Lu, W. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect J. Controlled Release 2010, 143 (1) 136-42
37. Cheng, Y.; Morshed, R. A.; Auffinger, B.; Tobias, A. L.; Lesniak, M. S. Multifunctional nanoparticles for brain tumor imaging and therapy Adv. Drug Delivery Rev. 2014, 66, 42-57
38. Zhan, C.; Lu, W. The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery Curr. Pharm. Biotechnol. 2012, 13 (12) 2380-7